Vesprini, Danny, et al. “The Therapeutic Ratio Is Preserved for Radiotherapy or Cisplatin Treatment in BRCA2-Mutated Prostate Cancers”. Canadian Urological Association Journal, vol. 5, no. 2, Apr. 2013, pp. E31-E35, doi:10.5489/cuaj.619.